Directory
>
Rob Mcdonald
Rob Mcdonald
Executive Director, Platform Biology | Kymera Therapeutics
Watertown, Massachusetts, United States
Rob Mcdonald
Summary
Rob McDonald is a seasoned leader in the field of platform biology, currently serving as the Executive Director at Kymera Therapeutics. With a robust educational background including a PhD in Cellular and Molecular Biology from the University of Pennsylvania, Rob has dedicated over two decades to advancing drug discovery and functional genomics. His expertise spans critical areas such as CRISPR technology and RNA interference, positioning him at the forefront of innovative cancer research. Rob's prior roles at Novartis Institutes for Biomedical Research have equipped him with extensive experience in oncology and drug development. He is not only recognized for his scientific contributions, evidenced by multiple publications in prestigious journals, but also for his leadership in directing complex projects and teams. Rob's career reflects a commitment to scientific excellence and a passion for translating research into therapeutic solutions. Outside of work, he is likely to be an advocate for sustainable practices in science and technology.
Rob Mcdonald
Work Experience
Executive Director, Platform Biology at
Kymera Therapeutics
July 2022 - Present
Senior Director, Platform Biology at
Kymera Therapeutics
October 2021 - July 2022
Associate Director at
Novartis
April 2020 - October 2021
Senior Investigator II at
Novartis
October 2019 - March 2020
Senior Investigator I at
Novartis
October 2014 - April 2019
Investigator III at
Novartis Institutes For Biomedical Research
April 2011 - October 2014
Investigator II at
Novartis
November 2009 - April 2011
Postdoctoral Researcher at
Harvard University
January 2003 - January 2009
Rob Mcdonald
Education
University of Pennsylvania, Phd
January 1995 - January 2003
Syracuse University, Bachelor Of Science (Bs)
January 1991 - January 1995
Frequently Asked Questions about Rob Mcdonald
What is Rob Mcdonald email address?
Rob Mcdonald's primary email address is *********@kymeratx.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Rob Mcdonald work for?
Rob Mcdonald is a Executive Director, Platform Biology at Kymera Therapeutics, a company specializing in Commercial physical research.
Where Rob Mcdonald graduated from?
Rob Mcdonald holds a degree in Cell/Cellular And Molecular Biology from University of Pennsylvania.
How can I directly contact Rob Mcdonald?
To contact Rob Mcdonald directly, you can use the email address *********@kymeratx.com. Complete contact information is available upon registration with Muraena.
Who is Rob Mcdonald?
Rob McDonald is a seasoned leader in the field of platform biology, currently serving as the Executive Director at Kymera Therapeutics. With a robust educational background including a PhD in Cellular and Molecular Biology from the University of Pennsylvania, Rob has dedicated over two decades to advancing drug discovery and functional genomics. His expertise spans critical areas such as CRISPR technology and RNA interference, positioning him at the forefront of innovative cancer research. Rob's prior roles at Novartis Institutes for Biomedical Research have equipped him with extensive experience in oncology and drug development. He is not only recognized for his scientific contributions, evidenced by multiple publications in prestigious journals, but also for his leadership in directing complex projects and teams. Rob's career reflects a commitment to scientific excellence and a passion for translating research into therapeutic solutions. Outside of work, he is likely to be an advocate for sustainable practices in science and technology.
Rob`s contact details
*********@kymeratx.com
Colleagues
Consultant
Executive Director
VP Preclinical Development
Chief Financial Officer
Vice President of Finance
Executive Director, Clinical Data Management
Executive Business Partner to the CEO
Executive Director, Biological Sciences
Founder, President and Chief Executive Officer
Executive Director, Immunology